In silico development of novels radiopharmaceuticals for positron emission tomography from inhibitors of mechanistic target of rapamycin (MTOR)

A. Ferino-Perez; Fritz-Line Velayoudom Cephise; L. Belia; Sarra Gaspard; Ulises Javier Jáuregui Haza

Poster communications

In silico development of novels radiopharmaceuticals for positron emission tomography from inhibitors of mechanistic target of rapamycin (MTOR)

A. Ferino-Perez Fritz-Line Velayoudom Cephise ¹ L. Belia Sarra Gaspard ² Ulises Javier Jáuregui Haza ³

1 Equipe de recherche sur le Risque Cardio métabolique

2 UA - Université des Antilles

3 Instituto Superior de Tecnologias y Ciencias Aplicadas - InSTEC (CUBA)

Document type :

Poster communications

Domain :

Chemical Sciences / Organic chemistry

Chemical Sciences / Radiochemistry

Complete list of metadatas

https://hal.univ-antilles.fr/hal-02425017
Contributor : Olivier Gros <>
Submitted on : Sunday, December 29, 2019 - 1:30:37 PM
Last modification on : Friday, January 24, 2020 - 7:42:14 PM

In silico development of novels radiopharmaceuticals for positron emission tomography from inhibitors of mechanistic target of rapamycin (MTOR)

Identifiers

Collections

Citation

Export

Metrics

51

In silico development of novels radiopharmaceuticals for positron emission tomography from inhibitors of mechanistic target of rapamycin (MTOR)

Identifiers

Collections

Citation

Export

Share

Metrics

51